FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.72B
1-Year Est. Return 129.71%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+129.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
-$170M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$57.8M
2
+$27M
3
+$25.5M
4
BBIO icon
BridgeBio Pharma
BBIO
+$20.9M
5
ANTX icon
AN2 Therapeutics
ANTX
+$15.7M

Top Sells

1
+$167M
2
+$58.8M
3
+$15.2M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$10.2M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.15M

Sector Composition

1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$204M 13.59%
6,470,392
+2,110,285
2
$132M 8.75%
9,781,472
3
$115M 7.62%
988,460
-1,800
4
$112M 7.46%
12,131,705
+1,259,902
5
$105M 6.97%
10,109,279
6
$71.9M 4.78%
2,725,949
+737,073
7
$59.4M 3.95%
1,164,405
8
$54.4M 3.61%
2,371,304
+204,082
9
$49.1M 3.27%
3,014,349
+70,000
10
$47.3M 3.14%
1,589,931
+175,108
11
$46.1M 3.07%
8,684,232
12
$34.2M 2.27%
2,985,757
13
$31.8M 2.11%
1,787,527
14
$31.2M 2.07%
3,238,859
15
$30.8M 2.05%
655,000
16
$28.7M 1.91%
+1,403,013
17
$27.6M 1.84%
997,455
+142,971
18
$23.4M 1.55%
+614,043
19
$22.3M 1.48%
+1,388,889
20
$17.6M 1.17%
746,479
21
$16.4M 1.09%
34,425
+6,000
22
$16.2M 1.07%
899,700
23
$15.1M 1.01%
+4,000,000
24
$15M 1%
6,881,090
25
$14.6M 0.97%
1,501,383
1
2 3